Dorsey & Whitney Trust’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$283K Buy
1,546
+40
+3% +$7.37K 0.02% 584
2025
Q4
$265K Buy
+1,506
New +$246K 0.01% 596
2020
Q2
Sell
-639
Closed -$202K 439
2020
Q1
$202K Buy
+639
New +$194K 0.03% 351
2018
Q4
Sell
-617
Closed -$218K 382
2018
Q3
$218K Buy
+617
New +$212K 0.03% 367
2017
Q1
Sell
-943
Closed -$268K 332
2016
Q4
$268K Sell
943
-113
-11% -$33.5K 0.06% 213
2016
Q3
$330K Buy
+1,056
New +$313K 0.08% 180
2016
Q2
Sell
-1,313
Closed -$341K 288
2016
Q1
$341K Sell
1,313
-230
-15% -$60.8K 0.09% 160
2015
Q4
$472K Buy
1,543
+96
+7% +$27.6K 0.12% 133
2015
Q3
$422K Buy
1,447
+43
+3% +$14.2K 0.12% 140
2015
Q2
$566K Buy
1,404
+43
+3% +$17.3K 0.14% 125
2015
Q1
$574K Sell
1,361
-185
-12% -$72.9K 0.15% 124
2014
Q4
$524K Buy
1,546
+309
+25% +$100K 0.14% 132
2014
Q3
$410K Buy
1,237
+133
+12% +$43.9K 0.11% 154
2014
Q2
$348K Sell
1,104
-31
-3% -$9.33K 0.08% 167
2014
Q1
$348K Sell
1,135
-126
-10% -$40K 0.08% 165
2013
Q4
$352K Buy
1,261
+218
+21% +$56.4K 0.1% 167
2013
Q3
$251K Sell
1,043
-92
-8% -$20.6K 0.07% 206
2013
Q2
$245K Buy
+1,135
New +$243K 0.08% 187

Other funds holding BIIB

Dorsey & Whitney Trust's BIIB Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its Biogen (BIIB) stake by 2.7% in Q1 2026, buying an estimated $7.37K and bringing the position to 1,546 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #584.

Dorsey & Whitney Trust first reported a position in BIIB in Q2 2013 and has held it in 18 quarters since. The position peaked at $574K in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Dorsey & Whitney Trust held 1,546 shares of Biogen worth $283K as of Q1 2026.
  • Dorsey & Whitney Trust bought 40 Biogen shares in Q1 2026, an estimated $7.37K.
  • Biogen made up 0.02% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #584 holding.
  • Dorsey & Whitney Trust first reported a position in Biogen in Q2 2013 and has held it in 18 quarters since.
  • Dorsey & Whitney Trust's Biogen position peaked at $574K in Q1 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.